Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $547 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.
October 19, 2023 | 4:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Elevance Health and maintained a price target of $547.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Elevance Health. The maintained price target of $547 suggests that the analyst believes the stock is undervalued at current levels, which could lead to upward price movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100